Regencell Bioscience Holdings Cash Flow Statement (2023-2025) | RGC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2023	Jun2025	Dec2025
Operating Activities
Gains from Investment Securities (Quarter)	6.66M
Change in Working Capital
Change in Accured Expenses (Quarter)		0.35M	1.41M
Other Working Capital Changes (Quarter)		0.01M